je.st
news
Swiss-based Helsinn Group and Mundipharma Sign for Rights to Phase...
2013-12-19 09:49:04| Logistics - Topix.net
The two companies sign a distribution and license agreement for an investigational therapy for the prevention of chemotherapy-induced nausea and vomiting covering , for netupitant-palonosetron fixed dose combination , a Helsinn product under development for the treatment of chemotherapy-induced nausea and vomiting.
Tags: to
rights
sign
group
Category:Transportation and Logistics
Latest from this category |
All news |
||||||||||||||||||
|
|||||||||||||||||||